Income Statement (TTM)
Moberg Pharma AB (publ) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 34 | 34 | 34 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 9 | 10 | 13 | 12 |
| Change (%) | 0.00 | 0.00 | 0.00 | -99.39 | 0.00 | 0.00 | 0.00 | -100.00 | ∞ | 501.10 | 78.21 | 11.69 | 31.08 | -3.99 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Cost Of Sales | 0 | 2 | 2 | 3 | 4 | 5 | |||||||||
| Change (%) | 423.17 | 35.84 | 49.98 | 27.92 | 11.43 | ||||||||||
| % of Revenue | 40.00 | 34.81 | 26.54 | 35.63 | 34.77 | 40.36 | |||||||||
| Gross Operating Profit | 34 | 34 | 34 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 6 | 8 | 7 |
| Change (%) | 0.00 | 0.00 | 0.00 | -99.39 | 0.00 | 0.00 | 0.00 | -100.00 | ∞ | 553.05 | 100.84 | -2.14 | 32.83 | -12.21 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 60.00 | 65.19 | 73.46 | 64.37 | 65.23 | 59.64 | |
| SG&A | 22 | 22 | 21 | 21 | 20 | 21 | 22 | 22 | 23 | 27 | 30 | 30 | 29 | 28 | 30 |
| Change (%) | 1.00 | -8.01 | 1.41 | -3.78 | 5.19 | 3.56 | 0.44 | 5.41 | 17.62 | 9.85 | -0.79 | -2.18 | -4.69 | 8.83 | |
| % of Revenue | 65.65 | 66.30 | 60.99 | 61.85 | 9,677.29 | 10,179.23 | 10,542.03 | 10,588.89 | 3,314.15 | 605.66 | 337.17 | 295.30 | 214.72 | 243.38 | |
| R&D | 6 | 6 | 6 | 5 | 2 | 1 | 1 | 2 | 3 | 4 | 3 | 2 | 302 | 302 | 303 |
| Change (%) | 1.07 | 3.11 | -9.41 | -68.27 | -29.01 | 19.80 | 58.23 | 27.52 | 32.16 | -22.39 | -15.94 | 12,220.83 | -0.11 | 0.27 | |
| % of Revenue | 16.45 | 16.62 | 17.14 | 15.53 | 800.97 | 568.60 | 681.16 | 1,077.78 | 458.54 | 59.20 | 27.93 | 3,080.52 | 2,347.46 | 2,451.51 | |
| OpEx | 24 | 26 | 23 | 23 | 21 | 21 | 22 | 22 | 24 | 30 | 34 | 34 | 335 | 334 | 338 |
| Change (%) | 7.78 | -8.54 | -2.29 | -9.71 | 0.00 | 6.04 | 1.60 | 8.02 | 24.19 | 14.42 | -0.32 | 879.65 | -0.21 | 1.11 | |
| % of Revenue | 70.79 | 76.30 | 69.79 | 68.19 | 10,011.59 | 10,011.59 | 10,616.43 | 10,786.47 | 3,652.80 | 695.33 | 388.95 | 3,411.46 | 2,597.08 | 2,735.05 | |
| Operating Income | 10 | 8 | 10 | 11 | -21 | -21 | -22 | -22 | -24 | -29 | -29 | -25 | -325 | -321 | -325 |
| Change (%) | -18.87 | 27.50 | 5.28 | -291.65 | -0.00 | 6.10 | 1.62 | 9.03 | 20.79 | 0.72 | -13.51 | 1,180.04 | -1.16 | 1.32 | |
| % of Revenue | 29.21 | 23.70 | 30.21 | 31.81 | -9,911.59 | -9,911.59 | -10,516.43 | -10,686.47 | -3,552.80 | -595.33 | -288.95 | -3,311.46 | -2,497.08 | -2,635.05 | |
| Interest Expense | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |
| Change (%) | 4.02 | -17.27 | -49.07 | 69.44 | 42.62 | 27.01 | 12.67 | -5.62 | -3.40 | 0.44 | -4.39 | -5.05 | |||
| % of Revenue | -3.03 | -3.15 | -2.61 | -1.33 | -34.78 | -58.94 | -84.06 | -30.37 | -4.77 | -2.58 | -2.32 | -1.70 | -1.68 | ||
| Net Income | 6 | 28 | 30 | 31 | -17 | -16 | -16 | -16 | -18 | -23 | -23 | -18 | -255 | -251 | -255 |
| Change (%) | 377.93 | 6.81 | 2.52 | -154.19 | -5.56 | 3.74 | -0.33 | 9.33 | 27.02 | 0.86 | -19.80 | 1,297.95 | -1.46 | 1.33 | |
| % of Revenue | 17.43 | 83.28 | 88.96 | 91.20 | -8,036.23 | -7,589.37 | -7,873.43 | -7,847.83 | -2,751.22 | -461.64 | -207.75 | -2,600.25 | -1,954.77 | -2,063.11 | |
Source: Capital IQ
